OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
87
Views
83
CrossRef citations to date
0
Altmetric
Review
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
Akihiro Ohmoto1 Laboratory of Clinical Genomics, National Cancer Center Research Institute, TokyoCorrespondence[email protected]
& Shinichi Yachida1 Laboratory of Clinical Genomics, National Cancer Center Research Institute, Tokyo;2 Department of Cancer Genome Informatics, Graduate School of Medicine, Faculty of Medicine, Osaka University, Osaka, Japan
Pages 5195-5208
|
Published online: 26 Oct 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.